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Abstract
Objective: In May 2009, after considering short and long-term maternal/child outcomes, the 
Institute of Medicine (IOM) revised recommendations for gestational weight gain (GWG); 
however preeclampsia was dismissed due to insufficient evidence. Our objective was to 
evaluate preeclampsia risk by angiogenic-biomarker profile by both BMI and GWG-
adherence. Given numerous studies showing adipose tissue's ability to stimulate 
angiogenesis, we hypothesized that overweight/obese (OW-OB) women and over-gainers 
(OG) would have altered angiogenic profiles as compared to underweight/normal-weight (U-
N) women and under-/appropriate-gainers (U-AG), respectively. 
Methods: Between 5/04-1/06, serial serum specimens collected from 94 women at high 
preeclampsia risk between 22-36 weeks. Soluble fms-like tyrosine kinase-1 (sFlt1), placental 
growth factor (PlGF) and soluble endoglin (sEng) measured by ELISA. BMI and GWG 
adherence categories determined by 1990 IOM recommendations. Within-women correlation 
and right-skewness handled by estimating linear mixed models for ln-transformed biomarkers 
and then exponentiating on ln scale (i.e.geometric means). T-test compared means in 3 
windows. 
Results: Analytic sample included 82 subjects (342 specimens) without multiples or 
pregnancy-related hypertension diagnosis. Mean sFlt1 lower in all windows in OW-OB 
compared to U-N - significant only at 22-26wks [506.2(95%CI 438.1-584.9) vs 745.5(95%CI 
595.9-932.6) p=0.04] and in OG compared to U-AG with significant comparisons (p=0.05) [22-
26wks: 492.1(95%CI 420.1-576.3) vs 691.3(95%CI 574.0-832.6); 27-30wks: 
570.1(95%CI488.1-665.9) vs 788.8(95%CI 656.8-947.4)]. Mean PlGF lower in all windows in 
OW-OB compared to U-N [22-26wks: 430.5(95%CI 359.0-516.3) vs 588.6(95%CI 444.3-
779.7) p=0.06; 27-30wks: 475.8(95%CI 398.7-567.8) vs 811.8(95%CI 614.3-1072.9) p=0.005; 
31-36wks: 428.5(95%CI 358.0-513.0) vs 724.6(95%CI 548.5-957.1) p=0.01] and in OG 
compared to U-AG with no significant comparisons. Mean ratio [(sFlt1+sEng):PlGF] trended 
higher in OW-OB compared to U-N women at 27-30 and 31-36wks and in OG compared to U-
AG at 31-36wks; however no windows with significant comparisons. 
Conclusion: Findings suggest trends that OW-OB BMI and excessive GWG associated with 
angiogenic biomarker profiles consistent with higher preeclampsia risk. Exploratory study 
limited by small numbers. BMI and GWG as potentially modifiable factors merit further 
investigation for preeclampsia risk alteration.
Background
• In May 2009, after considering short and long-term maternal/child 
outcomes, the Institute of Medicine (IOM) revised recommendations 
for gestational weight gain (GWG); however preeclampsia was 
dismissed due to insufficient evidence. 
IOM 2009
• Since change in recommendations, epidemiologic studies have 
since been published that support an association between GWG 
adherence and hypertensive disease of pregnancy.
AJOG 2009;200(2):167.e1-7
• Numerous studies have revealed adipose tissue's ability to 
stimulate angiogenesis
Cardiovascular Res 2008;78(2):286-93
Conclusion
• Findings suggest trends that OW-OB BMI and excessive GWG 
associated with angiogenic biomarker profiles consistent with 
higher preeclampsia risk by end of gestation.
• BMI and GWG as potentially modifiable factors merit further 
investigation for preeclampsia risk alteration.
Hypothesis
Materials & Methods
 Pregnant subjects  <24 weeks gestation enrolled from outpatient 
prenatal clinics at UMass Memorial Health Care between 
May 2004 and January 2006.
 Each subject had >1 of the following risk factors for preeclampsia:
Inclusion Criteria                       RR
Chronic HTN 2.37
Renal Disease/CKD -----
Pregestational DM  3.56
History of Preeclampsia              7.19
Teen Pregnancy (≤ 18)                2.98
Multi-fetal gestation    2.93 (twins)
2.83 (triplets)
Obesity (BMI > 30)     2.47
APL Ab Syndrome                      9.72
SLE                                                 -----
Duckitt K & Harrington D. BMJ. 2005
 Subjects recruited 127
Exclusions
missing outcomes 3
gestational HTN                   5
multiple gestationsa 25
preeclampsia diagnosisb 12
Subjects included in analyses 82
(342 samples)
Excluded due to association with altered angiogenic profile:
aMultiple gestations (n=20)  Maynard et al, AJOG, 2008;198:200
bHypertensive diseases of pregnancy (gestational HTN & preeclampsia)
Moore Simas et al, AJOG, 2007;197:244.e1-244.e8
 sFlt1, PlGF and sEndoglin levels were measured by ELISA
 BMI & GWG adherence categories by 1990 IOM recommendations
Adherence defined by GWG and GA @ last prenatal visit subtracted 
from pre-pregnancy weight; thus preterm and term deliveries included
Statistical Analysis
• Demographic comparisons utilized Fisher exact test for categorical 
variables and Wilcoxon rank sum test for continuous variables                      
(see Table 1)
• Within-women correlation and right-skewness handled by estimating 
linear mixed models for ln-transformed biomarkers and then 
exponentiating on ln scale (i.e., geometric means). 
• Geometric mean and 95% confidence intervals displayed for sFlt1, 
PlGF and (sFlt1+sEng):PlGF in each of 3 gestational-age windows for 
UW-N vs. OW-OB BMI and Under-Appropriate vs. Over-gainers (see 
figures 1-6)
• T-test compared means in 3 windows.  
We hypothesized that overweight/obese (OW-OB) women and 
over-gainers (OG) would have altered angiogenic profiles as 
compared to underweight/normal-weight (U-N) women and 
under-/appropriate-gainers (U-AG), respectively.
• Analytic sample included 82 subjects (342 specimens).
• See Table 1 for Demographic Comparisons.
• BMI Comparisons (see Figures1–3)
• Mean sFlt1 lower in all windows in OW-OB compared to U-N (Figure 1)
• Mean PlGF lower in all windows in OW-OB compared to U-N (Figure 2)
• Mean ratio [(sFlt1+sEng):PlGF] trended higher in OW-OB compared to U-N 
women at 27-30 and 31-36wks (Figure 3)
• GWG Adherence Comparisons (see Figures 4–6)
• Mean sFlt1 lower in all windows in OG compared to U-AG (Figure 4)
• Mean PLGF lower in all windows in OG compared to U-AG (Figure 5)
• Mean ratio [(sFlt1+sEng):PlGF] trended higher in OG compared to U-AG 
at 31-36wks (Figure 6)
Table 1. Demographic comparisons
Objective
To evaluate preeclampsia risk by angiogenic-biomarker 
profile by both BMI and GWG-adherence.
Demographic 
Characteristics
BMI Categories GWG Adherence Categories
Underweight
-Normal
Overwgt-
Obese
P-Value
Under/Appropr
Gain
Over-Gain
P-ValueMean±SD Mean±SD Mean±SD Mean±SD
Age (years) 25.9±8.5 31.1±6.6 0.01 29.6±7.9 29.5±7.4 NS
Gravity 2.4±1.7 2.9±1.8 NS 2.9±2.1 2.7±1.5 NS
Living Children 0.8±1.1 1.0±1.0 NS 0.9±1.1 0.9±1.0 NS
GA @ first PNV 
(wk)
11.8±4.4 12.0±6.0 NS 11.8±4.8 12.0±6.3 NS
SBP @ first PNV 
(mmHg)
114.0±12.5 119.5±13.7 NS 117.1±14.2 119.1±13.1 NS
DBP at first PNV 
(mmHg)
67.1±5.1 70.8±9.6 NS 70.0±8.4 69.9±9.4 NS
GA at delivery 
(wks)
38.6±2.2 38.0±2.7 NS 38.6±2.0 37.9±2.8 NS
Placenta weight 
(g)
443.8±90.1 443.6±206.
9
NS 526.4±155.7 371.3±176.2 NS
N (%) N (%) N (%) N (%)
Race/ethnicity
White
Hispanic
Black
Other
13 (54.2)
10 (41.7)
0 (0)
1 (4.2)
35 (60.3)
13 (22.4)
9 (15.5)
1 (1.7)
0.05
19 (55.9)
10 (29.4)
4 (11.8)
1 (2.9)
29 (60.4)
13 (27.1)
5 (10.4)
1 (2.9)
NS
Smoking Status
Current
Prior Pregnancy
Never
1 (4.2)
6 (25.0)
17 (70.3)
6 (10.3)
9 (15.5)
43 (74.1)
NS
4 (11.8)
5 (14.7)
25 (73.5)
3 (6.3)
10 (20.8)
35 (72.9)
NS
Chronic HTN 3 (12.5) 17 (29.3) NS 9 (26.5) 11 (22.9) NS
Pregestational 
DM
6 (25.0) 22 (37.9) NS 10 (29.4) 18 (37.5) NS
Renal Disease 4 (16.7) 1 (1.7) 0.02 5 (14.7) 0 (0) 0.01
Adolescent 
Pregnancy
8 (33.3) 6 (10.3) 0.02 7 (20.6) 7 (14.6) NS
History 
Preeclampsia
4 (16.7) 9 (15.5) NS 7 (20.6) 6 (12.5) NS
Lupus 4 (16.7) 2 (3.5) NS 4 (11.8) 2 (4.2) NS
Antiphospholipid
Syndrome
0 (0) 2 (3.5) NS 0 (0) 2 (4.2) NS
• Small sample size required collapsing of BMI and GWG-
adherence categories; thus unable to look at adherence 
within each BMI category
• Secondary analysis not powered for this exploratory analysis
• Only had total GWG at end of pregnancy
Limitations
Pre-pregnancy BMI Category
Pre-pregnancy 
BMI* (kg/m2)
Total GWG at 40 
weeks
Underweight (U) <19.8 28-40 lbs
Normal weight  (N) 19.8-26.0 25-35 lbs
Overweight (OW) 26.1-29.0 15-25 lbs
Obese (OB) >29.0 At least 15 lbs
Results
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Figures 1-3.  Angiogenic biomarker profiles comparing under-/normal-weight to overweight/obese at 3 gestational age windows 
BMI Category
(# specimen/ # women)
22-26 weeks 27-30 weeks 31-36 weeks
Underweight (<19.8) 5/4 6/3 7/4
Normal weight (19.8-26.0) 22/18 27/18 29/17
Overweight (26.0-29.0) 22/16 23/15 28/14
Obese (>29.0) 47/35 63/37 63/36
200
400
600
800
1000
1200
1400
22-26 27-30 31-36
SF
lt1
 (p
g/
m
l)
Gestational Age (Weeks)
200
400
600
800
1000
22-26 27-30 31-36
Pl
G
F
(p
g/
m
l) 
0
1
2
3
4
22-26 27-30 31-36
(S
Fl
t1
+s
En
g)
/P
lG
F
Gestational Age (Weeks)
Under/Appropriate-gainers
Over-gainers
4. Geometric mean sFlt1 (95% CI) 6. Geometric mean (sFlt1+sEng)/PlGF (95% CI) 5. Geometric mean PlGF (95% CI) 
GWG BMI-specific 
Adherence Category
(# specimen/ # women)
22-26 weeks 27-30 weeks 31-36 weeks
Under gainer 24/17 24/15 27/14
Appropriate gainer 18/13 25/15 29/15
Over gainer 54/43 70/43 71/42
Figures 4-6.  Angiogenic biomarker profiles comparing under/appropriate gainers to over-gainers at 3 gestational age windows 
p=0.04
p=0.05
p=0.01
p=0.01
p=0.06
p=0.05
